262 related articles for article (PubMed ID: 17260089)
1. Molecular targets of glioma invasion.
Nakada M; Nakada S; Demuth T; Tran NL; Hoelzinger DB; Berens ME
Cell Mol Life Sci; 2007 Feb; 64(4):458-78. PubMed ID: 17260089
[TBL] [Abstract][Full Text] [Related]
2. "...those left behind." Biology and oncology of invasive glioma cells.
Berens ME; Giese A
Neoplasia; 1999 Aug; 1(3):208-19. PubMed ID: 10935475
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
4. Glioma: an overview of current classifications, characteristics, molecular biology and target therapies.
Zeng T; Cui D; Gao L
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1104-15. PubMed ID: 25961548
[TBL] [Abstract][Full Text] [Related]
5. Novel facets of glioma invasion.
Fabian C; Han M; Bjerkvig R; Niclou SP
Int Rev Cell Mol Biol; 2021; 360():33-64. PubMed ID: 33962750
[TBL] [Abstract][Full Text] [Related]
6. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
7. Signaling determinants of glioma cell invasion.
Kwiatkowska A; Symons M
Adv Exp Med Biol; 2013; 986():121-41. PubMed ID: 22879067
[TBL] [Abstract][Full Text] [Related]
8. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.
Pei J; Park IH; Ryu HH; Li SY; Li CH; Lim SH; Wen M; Jang WY; Jung S
Radiat Oncol; 2015 Aug; 10():164. PubMed ID: 26245666
[TBL] [Abstract][Full Text] [Related]
9. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.
Bellail AC; Hunter SB; Brat DJ; Tan C; Van Meir EG
Int J Biochem Cell Biol; 2004 Jun; 36(6):1046-69. PubMed ID: 15094120
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of collagen XVI expression reduces glioma cell invasiveness.
Bauer R; Ratzinger S; Wales L; Bosserhoff A; Senner V; Grifka J; Grässel S
Cell Physiol Biochem; 2011; 27(3-4):217-26. PubMed ID: 21471710
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte elevated gene-1: a novel target for human glioma therapy.
Emdad L; Sarkar D; Lee SG; Su ZZ; Yoo BK; Dash R; Yacoub A; Fuller CE; Shah K; Dent P; Bruce JN; Fisher PB
Mol Cancer Ther; 2010 Jan; 9(1):79-88. PubMed ID: 20053777
[TBL] [Abstract][Full Text] [Related]
13. Invasion of human glioma: role of extracellular matrix proteins.
Chintala SK; Rao JK
Front Biosci; 1996 Nov; 1():d324-39. PubMed ID: 9159237
[TBL] [Abstract][Full Text] [Related]
14. Tumor Cell Invasion in Glioblastoma.
Vollmann-Zwerenz A; Leidgens V; Feliciello G; Klein CA; Hau P
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178267
[TBL] [Abstract][Full Text] [Related]
15. Biological mechanisms of glioma invasion and potential therapeutic targets.
Tysnes BB; Mahesparan R
J Neurooncol; 2001 Jun; 53(2):129-47. PubMed ID: 11716066
[TBL] [Abstract][Full Text] [Related]
16. Signaling Determinants of Glioma Cell Invasion.
Kwiatkowska A; Symons M
Adv Exp Med Biol; 2020; 1202():129-149. PubMed ID: 32034712
[TBL] [Abstract][Full Text] [Related]
17. The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75
Alshehri MM; Robbins SM; Senger DL
Vitam Horm; 2017; 104():367-404. PubMed ID: 28215302
[TBL] [Abstract][Full Text] [Related]
18. Caffeine suppresses the progression of human glioblastoma via cathepsin B and MAPK signaling pathway.
Cheng YC; Ding YM; Hueng DY; Chen JY; Chen Y
J Nutr Biochem; 2016 Jul; 33():63-72. PubMed ID: 27260469
[TBL] [Abstract][Full Text] [Related]
19. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
Miletic H; Niclou SP; Johansson M; Bjerkvig R
Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
[TBL] [Abstract][Full Text] [Related]
20. Cilengitide treatment for malignant glioma: current status and future direction.
Kurozumi K; Ichikawa T; Onishi M; Fujii K; Date I
Neurol Med Chir (Tokyo); 2012; 52(8):539-47. PubMed ID: 22976135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
